Skip to main content

Table 3 Body weight gain and T3 levels after 16 weeks of iodine treatment.

From: Antineoplastic effect of iodine in mammary cancer: participation of 6-iodolactone (6-IL) and peroxisome proliferator-activated receptors (PPAR)

Treatment Body weight gain (g) T3 (ng/dl)
Control 154 ± 15 63.7 ± 10
MNU 157 ± 12 67.9 ± 3
Control + I2 152 ± 9 63.2 ± 11
MNU + I2 150 ± 16 60.2 ± 5.6